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Enterotoxigenic Escherichia coli (ETEC) are common causes of diarrheal morbidity and
mortality in developing countries for which there is currently no vaccine. Heterogeneity in
classical ETEC antigens known as colonization factors (CFs) and poor efficacy of toxoid-
based approaches to date have impeded development of a broadly protective ETEC vac-
cine, prompting searches for novel molecular targets.
Methodology
Using a variety of molecular methods, we examined a large collection of ETEC isolates for
production of two secreted plasmid-encoded pathotype-specific antigens, the EtpA extra-
cellular adhesin, and EatA, a mucin-degrading serine protease; and two chromosomally-en-
coded molecules, the YghJ metalloprotease and the EaeH adhesin, that are not specific to
the ETEC pathovar, but which have been implicated in ETEC pathogenesis. ELISA assays
were also performed on control and convalescent sera to characterize the immune re-
sponse to these antigens. Finally, mice were immunized with recombinant EtpA (rEtpA),
and a protease deficient version of the secreted EatA passenger domain (rEatApH134R) to
examine the feasibility of combining these molecules in a subunit vaccine approach.
Principal Findings
EtpA and EatA were secreted by more than half of all ETEC, distributed over diverse
phylogenetic lineages belonging to multiple CF groups, and exhibited surprisingly little se-
quence variation. Both chromosomally-encoded molecules were also identified in a wide
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variety of ETEC strains and YghJ was secreted by 89% of isolates. Antibodies against both
the ETEC pathovar-specific and conserved E. coli antigens were present in significantly
higher titers in convalescent samples from subjects with ETEC infection than controls sug-
gesting that each of these antigens is produced and recognized during infection. Finally, co-
immunization of mice with rEtpA and rEatApH134R offered significant protection against
ETEC infection.
Conclusions
Collectively, these data suggest that novel antigens could significantly complement current
approaches and foster improved strategies for development of broadly protective
ETEC vaccines.
Author Summary
Infectious diarrhea is one of the leading causes of death among young children in develop-
ing countries, and a major cause of morbidity in all age groups. The enterotoxigenic
Escherichia coli contribute substantially to this burden of diarrheal illness, and have been a
focus of vaccine development efforts for more than forty years following their discovery as
a cause of severe diarrheal illness. The heat-labile, and/or heat stable enterotoxins that de-
fine ETEC are produced by a diverse population of Escherichia coli. This inherent genetic
plasticity of E. coli has made it difficult to identify antigens specific to ETEC that are highly
conserved. Therefore, identification of protective antigens shared by many ETEC strains
will likely play an essential role in development of the next iteration of vaccines.
Introduction
The enterotoxigenic Escherichia coli (ETEC) are among the most common causes of infectious
diarrhea worldwide. Importantly, ETEC are disproportionately represented in cases of severe
diarrheal illness as well as in deaths due to diarrhea among young children in developing coun-
tries [1].
These pathogens cause diarrhea by the elaboration and effective delivery of heat-labile and/
or heat-stable enterotoxins to intestinal epithelial cells where they stimulate production of cy-
clic nucleotides ultimately activating the cystic fibrosis transmembrane regulator (CFTR) with
resulting net efflux of fluid into the intestinal lumen[2]. Plasmid-encoded colonization factors
(CFs), discovered [3] shortly after these organisms were identified as a causative agent of chol-
era-like diarrheal illness[4–6], are thought to be essential for effective colonization of the small
intestine and required for ETEC pathogenesis.
Following early studies suggesting a pivotal role for these structures[7,8], CF antigens have
defined the basis for most subsequent ETEC vaccine efforts [9,10]. However, one factor com-
plicating development of a broadly protective vaccine for ETEC has been the general plasticity
of E. coli genomes[11], and the significant antigenic heterogeneity of the CFs. To date, at least
26 antigenically distinct CF antigens have been described[12]. The lack of appreciable cross-
protection afforded by these antigens combined with the complex landscape of CFs portrayed
in ETEC molecular epidemiology studies continue to complicate rational CF antigen selection
[13].
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Antigenic heterogeneity, recent failure of LT-toxoid-based vaccine strategies[14,15], as well
as the need to optimize the performance of live-attenuated vaccines currently in clinical trials
[16–18] have highlighted the need to identify additional virulence molecules that might be tar-
geted in ETEC vaccines. Recent efforts led to the identification of two loci discovered on the
same virulence plasmid of ETEC strain H10407 that encodes the CFA/I colonization factor.
These include the etpBAC two partner secretion locus responsible for production and export of
EtpA[19], a novel adhesin molecule which bridges highly conserved regions of flagellin and the
eukaryotic cell surface[20]. Also located on this plasmid is the eatA gene that encodes the EatA
serine protease autotransporter molecule[21] capable of degrading EtpA[22] as well as MUC2
[23], the major gel-forming soluble mucin in the small intestine[24].
Recent immunoproteomic[25] and transcriptomic [26] analyses of H10407 have also
highlighted two chromosomally encoded antigens that are not specific to the ETEC pathovar,
but which nonetheless appear to be involved in the pathogenesis of these organisms. Conceiv-
ably, these molecules, YghJ[27], a secreted mucin-degrading metalloprotease, and EaeH [28],
an adhesin, act in concert with colonization factors and other pathovar-specific virulence pro-
teins like EatA and EtpA to promote toxin delivery.
While emerging data suggests that these novel proteins are highly immunogenic[25] and
that EtpA and EatA are protective antigens[29–31] in a murine model of ETEC infection, addi-
tional data regarding their conservation among ETEC strains are needed to determine their
suitability as vaccine targets. Here we demonstrate that these antigens are broadly represented
in a diverse collection of ETEC isolates suggesting that they could be employed to augment ex-
isting approaches to ETEC vaccine development.
Materials and Methods
Bacterial strains and growth conditions
ETEC strains used in this study are detailed in S1 Dataset. All strains were grown at 37° in Cas-
samino acids yeast extract media[32] (CAYE: 2.0% Casamino Acids, 0.15% yeast extract, 0.25%
NaCl, 0.871% K2HPO4, 0.25% glucose, and 0.1% (v/v) trace salts solution consisting of 5%
MgSO4, 0.5% MnCl2, 0.5% FeCl3) from frozen glycerol stocks maintained at −80°C.
Strain characterization by disease severity and colonization factor type
Strains from the International Centre for Diarrhoeal Disease Research (icddr,b) in Dhaka were
selected based on their associated disease severity using modified WHO guidelines as previous-
ly outlined[33]. Expression of individual CFs was determined by dot immunoblotting with
monoclonal antibodies specific to each respective CFs (CF-MAb) as previously described [34].
Briefly, 2 μl of a PBS suspension containing*106 colony forming units of each ETEC strain
was dotted onto nitrocellulose, air-dried, blocked with BSA in PBS, followed by detection with
CF-MAbs and goat anti-mouse IgG_HRP conjugate. Bound MAbs were then detected with
4-chloro-1-naphthol chromogen and H2O2.
Screening for ETEC virulence genes by PCR
We screened a total of 181 ETEC available isolates currently maintained as frozen glycerol
stocks in our laboratories. The majority of these strains were collected between 1998 and 2011
in Bangladesh, and were obtained from the icddr,b in Dhaka. Complementing this collection
were geographically disparate strains associated with severe diarrheal illness including strains
from the Amazon region in Brazil [35], and ThroopD, an isolate from a patient with severe
ETEC diarrheal illness who presented in Dallas in the 1970s[36]. Strains encoding eatA and
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etpA were identified by PCR using primers directed against conserved regions of these genes as
previous described [37]. Briefly, a small amount of frozen glycerol stock from each strain was
introduced with a sterile pipette tip into a PCR mixture containing the respective primers and
a master mix. Toxin genotypes were confirmed in these isolates using multiplex PCR screening
for genes encoding heat-labile (LT), and heat-stable toxins (STp, and STh) as previously de-
scribed[34]. Primer sequences are listed in S1 Table.
Immunoblotting for secreted ETEC virulence antigens
To determine production of secreted virulence antigens by different ETEC strains, superna-
tants from overnight cultures were first precipitated with trichloroacetic acid (TCA) [19] and
resuspended in sample buffer before polyacrylamide gel electrophoresis. Western blotting was
then performed using polyclonal rabbit antisera against recombinant versions of either EatA
[21], EtpA[19], or YghJ[27] that were pre-absorbed against an E. coli lysate column (Pierce)
and affinity-purified using the antigen immobilized on nitrocellulose membranes as previously
described [31,38], followed by detection with affinity-purified secondary goat anti-rabbit-
(IgG)-HRP conjugate (Santa Cruz Biotechnology, SC2004).
Protein sequence comparisons of ETEC pathovar specific antigens
To examine antigenic conservation of EatA among ETEC isolates for which genomic DNA se-
quences are currently available, BLASTP[39] was used to search GenBank https://www.ncbi.
nlm.nih.gov/genbank/ using the full length sequence of the EatA protein from strain H10407
(https://www.ncbi.nlm.nih.gov/protein/AAO17297.1) as the query sequence. To construct
alignments of EatA from positive strains, the 1042 residue passenger domain (corresponding
to amino acids 57–1098 of EatA from H10407) was compared with EatA of ETEC isolates de-
rived from different phylogenic lineages using a CLUSTAL Omega (release 1.2.0 AndreaGia-
como) [40] algorithm plugin for CLCMain Workbench v6.9.1. A similar approach was used to
compare the amino-terminal sequence of EtpA (amino acids 1–600, GenBank accession num-
ber AAX13509.2).
Conservation heat mapping
Virulence protein expression data from the collection of 181 strains under study were included
in the analysis. Heat maps were configured using R[41] version 3.1.0 (2014, http://www.R-
project.org/) using gplots[42] and RColorBrewer[43] packages installed from http://CRAN.R-
project.org using the heatmap2 function within gplots (see S2 Dataset).
Recombinant protein production
The antigens used in these studies were produced as polyhistidine-tagged recombinant proteins
and purified by immobilized metal ion affinity chromatography (IMAC) as previously de-
scribed[27,29,44,45]. Additional polishing steps including size exclusion or ion exchange chro-
matography were performed as needed to produce highly purified antigens. Purity of each
antigen was assessed by SDS-PAGE followed by sensitive Coomassie Blue staining. Purified re-
combinant antigens were stored at −80°C.
Assessment of immune responses to novel ETEC virulence proteins
To quantitfy antibody concentrations directed at novel recombinant antigens, kinetic ELISA
was performed on dilutions of plasma samples previously obtained from patients hospitalized
at the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh (icddr,b)
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with acute symptomatic ETEC infections. Plasma samples from non-infected adults and chil-
dren obtained at icddr,b, or specimens obtained from children at Saint Louis Children’s Hospi-
tal were used as negative controls. Samples from human volunteer ETEC H10407 challenge
studies were kindly provided by Dr. Robert Gormely and Dr. Stephen Savarino of National
Naval Medical Center, Bethesda Maryland.
Use of these clinical materials was approved by the Institutional Review Boards of both
icddr,b and Washington University School of Medicine. All plasma samples were maintained
at 4°C in a humidified chamber prior to use in ELISA. Immune responses to purified recombi-
nant proteins (rYghJ, rEaeH, rEtpA, rEatAp) were assessed by kinetic ELISA[46] as previously
described [30,47]. Antigen binding to ELISA wells (Corning, Costar 2580) was first optimized
to determine the optimal coating concentration and buffer system, using highly antigen-specif-
ic polyclonal rabbit antisera to detect binding by ELISA. Purified antigens were then diluted ei-
ther in 50 mM carbonate buffer (pH 9.6) (rEtpA-myc-His6, 1 μg/ml; rEatAp, 10 μg/ml; rYghJ-
myc-His6, 1 μg/ml); or in phosphate buffered saline (PBS, pH 7.4) (rEaeH-myc-His6, 1 μg/ml).
ELISA plate wells were coated with 100 μl/well overnight at 4°C, washed with PBS containing
0.05% Tween-20 (PBS-T), and blocked for 1 h at 37°C with 1% BSA in PBS-T. All plasma sam-
ples were diluted at 1:4096 in blocking buffer. After incubation for 1 hour at 37°C, plates were
washed with PBS-T, and secondary goat anti-human IgG(H+L)-HRP conjugated antibody
(Pierce, 31410) was added at a final concentration of 1:10,000. After incubation for 30 minutes
at 37°C, plates were washed and developed with TMB microwell peroxidase substrate [3,3’,5,5’-
Tetramethylbenzidine] (KPL, 50-76-00). Kinetic absorbance measurements were determined
at a wavelength of 650 nm, and acquired at 40 s intervals for 20 minutes using a microplate
spectrophotometer (Eon, BioTek). All data were recorded and analyzed using Gen5 software
(BioTek) and reported as the Vmax expressed as milliunits/min. Statistical calculations were
performed using Prism v4.0c (GraphPad Software), using nonparametric Mann-Whitney
(two-tailed) comparisons of data.
Mouse immunization and challenge studies
These studies were performed in strict accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National Institutes of Health, using an estab-
lished protocol approved by the Washington University School of Medicine Animal Studies
Committee.
Four groups of twelve CD-1 mice were immunized intranasally with either 1 μg of LT (adju-
vant only controls), or 1 μg of LT + 15 μg of rEatAp(H134R), or 1 μg of LT + 15 μg of rEtpA,
or 1 μg of LT + 15 μg of rEatA(H134R)+15 μg of rEtpA on days 0, 14, 28. On day 40, mice were
treated with streptomycin [5 g per liter] in drinking water for 24 hours, followed by drinking
water alone for 18 hours. After administration of famotidine to reduce gastric acidity, mice
were challenged with 106 cfu of the kanamycin-resistant (lacZYA::KmR) strain jf876[48] by
oral gavage as previously described[47]. Fecal samples (6 pellets/mouse) were collected on day
42 before oral gavage, re-suspended in buffer (10mM Tris, 100mMNaCl, 0.05% Tween 20,
5mM Sodium Azide, pH 7.4) overnight at 4°C, centrifuged to pellet insoluble material, and re-
cover supernatant for fecal antibody testing (below). Twenty-four hours after infection, mice
were sacrificed, sera were collected, and dilutions of saponin small-intestinal lysates were plat-
ed onto Luria agar plates containing kanamycin (50 μg/ml).
Murine immune responses to LT, EatA and EtpA were determined using previously
described kinetic ELISA. Briefly, ELISA wells were coated with 1 μg/ml GM1, or 10 μg/ml
of rEatAp(H134R), or 1 μg/ml rEtpA in carbonate buffer (15 mMNa2CO3, 35 mM
NaHCO3, 0.2 g/L NaN3, pH8.6) overnight at 4°C. Wells were washed three times with
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phosphate-buffered saline containing 0.05% Tween 20 (PBS-T), blocked with 1% bovine serum
albumin (BSA) in PBS-T for 1 h at 37°C, and 100 μl of fecal suspensions (undiluted) or sera (di-
luted 1:100 in PBS-T with 1% BSA) was added per ELISA well and incubated at 37°C for 1 h.
Horseradish peroxidase-conjugated secondary antibodies were used and signal detected with
TMB (3,30,5,50-tetramethylbenzidine)-peroxidase substrate (KPL) substrate.
Ethics statement
All animal studies were performed under protocols approved by the Animal Studies Commit-
tee of Washington University School of Medicine (protocol number 20110246A1). All proce-
dures complied with Public Health Service guidelines, and The Guide for the Care and Use of
Laboratory Animals.
All human studies included were performed under a protocol approved by the Institutional
Review Board of Washington University School of Medicine (IRB ID# 201110126). All of the
human studies here report anonymous analysis of de-identified pre-existing sera previously
stored from earlier studies for which no additional consent was obtained.
Results
Conservation of ETEC pathogen-specific secreted antigens
Two novel antigens, the EtpA adhesin, and the passenger domain of the EatA serine protease
are encoded on the large 92 kilobase virulence plasmid of the prototypical ETEC strain
H10407. Both of these secreted proteins[22,30] are required for H10407 to efficiently deliver
heat-labile toxin to target epithelial cells. Furthermore, both of these antigens are immunogenic
[25], and induce protective immune responses in a murine model of ETEC intestinal coloniza-
tion[29,31]. To further assess their utility as potential vaccine antigens, we examined a large
collection of ETEC strains that were well characterized with respect to associated clinical meta-
data pertaining to disease severity and which had not undergone repeated serial passage in
the laboratory.
Altogether, we found that these antigens are relatively conserved in the ETEC pathovar,
confirming the results of earlier studies that focused on strains from different phylogenies ob-
tained in Guinea Bissau and Chile [37,49]. Of the 181 strains examined in the present study
(Fig. 1), we found that more than half of all strains produced EtpA (102/181, 56%) and/or EatA
(106/181, 59%) (S1 Dataset), and that more than three quarters of all strains produced at least
one of these antigens. Both EtpA and EatA were identified more than twice as frequently as the
most commonly identified CF (CS6), which was identified in 22% of strains in this collection
(Table 1).
Relationship of plasmid-encoded virulence loci to colonization factor
antigens
Importantly, although the genes encoding the etpBAC secretion system[19] and the EatA auto-
transporter[21] were initially discovered on the same large virulence plasmid of H10407, which
also encodes the colonization factor (CF) CFA/I, we found that these loci were not restricted to
strains expressing this particular CF, but were widely distributed among the different CFs, and
were also present in strains for which no CF could be identified (Fig. 2A). Indeed, half of the
strains for which no CF could be identified expressed either EtpA or EatA, suggesting that
these antigens could complement existing vaccination strategies centered on CFs. As expected
by the association with multiple CFs, we also found that EtpA and EatA were secreted by
strains from multiple phylogenic lineages (Fig. 2B, C). Interestingly, however we found a
Novel Conserved Immunogenic ETEC Antigens
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Figure 1. Relationship of strain subsets used in antigen expression studies, and strains with available
whole genome sequences. All of the strains in the collection (n = 181) were examined for production of
three secreted ETEC virulence proteins EtpA, EatA, and YghJ by immunoblotting of culture supernatants with
the respective antibodies. A subset of these strains (n = 91) were recently sequenced at the Genome
Sequencing Center for Infectious Diseases (GSCID).
doi:10.1371/journal.pntd.0003446.g001
Table 1. Distribution of EtpA and EatA among strains expressing different colonization factors.
CF1 total (n) EtpA n+ (%)2 EatA n+ (%)2 EtpA n+ or EatA n+ (%)2
CFA/I 21 17 (81) 17 (81) 18 (85)
CFA/II3
cs1 14 12 (86) 12 (86) 13 (93)
cs2 10 8 (80) 7 (70) 9 (90)
cs3 25 21 (84) 19 (76) 23 (92)
CFA/IV3
cs4 7 1 (14) 3 (43) 3 (43)
cs5 23 0 (0) 18 (78) 18 (78)
cs6 39 3 (8) 25 (64) 26 (67)
Other CFs
cs7 16 14 (88) 15 (94) 15 (94)
cs8 2 0 (0) 2 (100) 2 (100)
cs14 14 12 (86) 2 (14) 13 (93)
cs17 10 9 (90) 9 (90) 9 (90)
cs21 17 14 (82) 14 (82) 16 (94)
nd 36 16 (44) 7 (19) 18 (50)
1expression as determined with corresponding monoclonal antibody
2refers to strains expressing proteins as determined by immunoblotting nd: not detected with any of the
above monoclonal antibodies
3(CFA/II pili are typically comprised of CS1 or CS2 in combination with CS3; CFA/IV pili may be formed by
CS4 or CS5 in combination with CS6 or CS6 alone.)
doi:10.1371/journal.pntd.0003446.t001
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negative association between the etpBAC locus and strains expressing CFA/IV antigens [50,51]
including CS5 in that none of the 23 strains possessing CS5 fimbriae secreted the EtpA adhesin.
Similarly, among strains expressing CS6, which is frequently co-expressed with CS5, only a
minority secreted EtpA. These data are also consistent with our earlier observation that the
prototype B7A strain, which also expresses CS6, lacks the etpBAC locus and does not secrete
EtpA[19].
Figure 2. Conservation of novel pathotype-specific antigens EtpA and EatA among phylogenically distinct strains expressing different
colonization factors. a. Heatmap of EtpA and EatA showing the proportion of strains positive for expression of these antigens among different CF groups.
CF antigen designation is shown at left of the heatmap. nd = no CF antigen detected. Below is the heatmap key depicting colors associated with each degree
of antigen positivity. Density line in yellow depicts the relative number of map features assigned at each proportion. Primary data used to construct the
heatmap can be found in S2 Dataset. b. Imunoblot detection of EtpA and EatA expression among strains from different phylogenies. The upper immunoblot
demonstrates EtpA production in the prototype H10407 strain, ThroopD isolated in Dallas, TX in 1975, the Juruá_18/11 (Amazon, 1998), and phylogentically
dispersed strains from icddr,b. The etpAmutant is included as a negative control. The lower blot demonstrates EatA production by H10407, phylogenically
distributed strains from icddr,b and Envira_10/1, an additional isolate from cholera-like outbreaks in the Amazon. The eatAmutant is included as a negative
control. c. Phlyogram showing the phylogenetic distribution of selected ETEC strains (designations in blue) and reference E. coli strains (designations in
black). Red circles and gold stars represent eatA+, and etpA+ strains, respectively.
doi:10.1371/journal.pntd.0003446.g002
Novel Conserved Immunogenic ETEC Antigens
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003446 January 28, 2015 8 / 19
Interestingly, both the eatA and etpBAC loci were originally identified in ETEC strain
H10407, originally isolated from an adult with severe, cholera-like illness in Bangladesh[52].
As has been noted previously, this strain also causes more severe illness in human clinical chal-
lenge studies relative to other strains like B7A that lack these loci[53]. Because we had clinical
metadata pertaining to disease severity for all of the strains in our collection, we questioned
whether the production of either of these antigens was associated with strains isolated from
more severe forms of infection. However, we did not find any clear association between either
of these putative virulence loci and clinical outcome (S1 Dataset).
Conservation of chromosomally-encoded antigens
We also examined the conservation of two chromosomally-encoded antigens which are not
specific to the ETEC pathovar, but have recently been shown to play a role in virulence. The
eaeH gene was originally identified on the chromosome of ETEC strain H10407 by subtractive
hybridization with E. coliMG1655[54], is transcriptionally activated by cell contact [26], and
under these conditions EaeH is produced by a diverse group of strains belonging to different
phylogenies[28]. Using the EaeH peptide sequence from H10407 (GenBank accession
AAZ57201), BLASTP searches of recently sequenced ETEC strains from Bangladesh and else-
where (http://gscid.igs.umaryland.edu/wp.php?wp = comparative_genome_analysis_of_
enterotoxigenic_e._coli_isolates_from_infections_of_different_clinical_severity) also revealed
that the eaeH gene was present in 63 out of 91 distinct isolates (69%) (S1 Dataset). BLASTP
searches of these data for another chromosomally encoded molecule, YghJ, a type II secretion
system effector[55] recently shown to be involved in mucin degradation and toxin delivery[27]
demonstrated that the yghJ gene was present on the chromosomes in 83 of 91 (91%) isolates.
Similarly, we identified the YghJ protein in a majority (161/181, 89%) of ETEC culture super-
natants (S1 Dataset). This antigen was produced across ETEC strains expressing multiple CF
types including 31/36 strains that were CF-negative by monoclonal antibody screening.
EatA and EtpA sequence conservation
Ideally, putative vaccine targets should be specific to the pathovar under study or restricted to
pathogenic isolates, but not subject to significant antigenic variation. Therefore to further ex-
amine the potential utility of two ETEC pathovar specific antigens, EtpA and EatA, as vaccine
candidates, we used recently obtained DNA sequence information from multiple ETEC ge-
nomes belonging to different phylogenies and from temporally and geographically disparate
sources to compare the predicted amino acid sequences of these proteins.
For the prototype EatA molecule, first described in ETEC H10407[21], the 1042 residue re-
gion from amino acids 57–1098 is predicted for the secreted passenger domain that contains
the serine protease catalytic triad[21] as well as protective epitopes[23]. We therefore com-
pared this region of the molecule to those derived from the recently released genome sequences
of multiple ETEC strains. Altogether, we found that the sequence of the EatA passenger do-
main (EatAp) was very highly conserved across strains, and exhibited between 95–100% identi-
ty to the prototype H10407 Eatp (Table 2). Likewise, the predicted serine protease catalytic
motif formed by the histidine, aspartic acid and serine residues at positions 134, 162, and 267,
respectively were universally conserved within the passenger domains of these proteins (S1
Fig.). Similarly, the predicted amino acid sequences of the secreted EtpA adhesin molecules
from multiple strains exhibited between 94 and 100% identity to the H10407 prototype antigen
(Table 3, S2 Fig.).
Despite the fact that the comparator strains included here spanned isolates collected over
nearly 40 years, belonging to different phylogenies and that strains originated in diverse
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locations in Asia, Africa and the Americas, both proteins appear to exhibit remarkably little an-
tigenic variation. Likewise, in analysis of the genomes of strains isolated recently within Bangla-
desh both proteins demonstrated similar degrees of sequence conservation (S1–S2 Fig.).
Immunogenicity of novel virulence antigens
Earlier immunoproteomic studies suggested that a variety of conserved E. coli proteins as well
as ETEC pathovar specific proteins are recognized during the course of experimental infections
in mice, and these responses parallel those observed using pooled convalescent sera from
ETEC patients[25]. To further characterize the immune response to novel antigens we focused
on four proteins that have recently been shown to play a role in ETEC pathogenesis, including
two plasmid-encoded secreted ETEC pathovar-specific antigens: EatA protease, and the EtpA
adhesin, as well as the highly conserved chromosomally-encoded YghJ metalloprotease and the
EaeH adhesin protein.
In comparing convalescent plasma from patients hospitalized at icddr,b to uninfected con-
trols from Bangladesh, we found that patients in general exhibited significantly greater total an-
tibody (IgG, IgM, IgA) responses to each of these antigens following diarrheal illness (Fig. 3)
suggesting that these proteins are expressed during the course of infection. Similar results were
Table 2. EatA sequence conservation in geographically, temporally, and phylogenically disparate isolates.
strain accession origin isolation reported phenotype identity1 (%) Similarity (%) ref.
H10407 Q84GK0.1 Bangladesh 1973 cholera-like - - [52]
Throop D 2EMW91712.1 Dallas, TX 1976 cholera-like 98 99 [36]
Envira 10/1 2EMX71514.1 Amazon, Brazil 1998 cholera-like 97 98 [35]
Juruá 18/11 2EMX58104.1 Amazon, Brazil 1998 cholera-like 96 98 [35]
2850750 2EMW01116.1 Bangladesh 2008 cholera-like 96 97 5
2871950 2EMV49671.1 Bangladesh 2008 cholera-like 96 98 5
P0305293.1 2EMZ82436.1 Bangladesh 2011 cholera-like 97 98 5
P0304777.1 2EMX02137.1 Bangladesh 2011 cholera-like 96 97 5
2720900 2EMX91421.1 Bangladesh 2007 cholera-like 100 100 5
178900 2ENA71292.1 Bangladesh 2010 cholera-like 98 99 5
180200 2ENA61350.1 Bangladesh 2010 cholera-like 96 98 5
2722950 2EMZ73955.1 Bangladesh 2007 mild-self-limited 98 99 5
tw10598 3AELA00000000.1 Guinea-Bissau 1996 diarrhea4 96 98 [49]
tw10722 3AELB00000000.1 Guinea-Bissau 1996 diarrhea4 95 98 [49]
tw10828 3AELC00000000.1 Guinea-Bissau 1996 diarrhea4 95 97 [49]
tw11681 3AELD00000000.1 Guinea-Bissau 1996 diarrhea4 98 99 [49]
B2C ETS27975.1 Vietnam 1971 diarrhea4 96 98 [62]
E24377A YP_001451588.1 Egypt 1980s diarrhea4 96 97 [63]
1based on BLAST-P searches against 1042 residues of predicted passenger domain of H10407.
2sequenced at GSCID (http://gscid.igs.umaryland.edu/wp.php?wp = comparative_genome_analysis_of_enterotoxigenic_e._coli_isolates_from_infections_
of_different_clinical_severity)
3open reading frames corresponding to the eatA gene were ﬁrst assembled from whole genome shotgun sequence contigs for these draft genomes;
BLASTP for these homologues was conducted using CLC Main Workbench v6.9.1 and local database of predicted protein sequences derived from
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obtained in comparing plasma from un-infected children from a non-endemic area in the
United States (S3 Fig.).
We also examined the immune response to EtpA following infection by examining sera ob-
tained before and after challenge of human volunteers with ETEC H10407. In sera obtained
from two independent volunteer challenge studies, we also observed significant increases in im-
mune responses to EtpA (S4 Fig.), strongly suggesting that this secreted protein is specifically
recognized following infection by ETEC strains including H10407 that secrete this antigen.
Protective efficacy of combined EtpA-mutant EatA passenger
vaccination
Previous studies have demonstrated that individually, vaccination with either EtpA[31,56] or
the passenger domain of the EatA serine protease[29] affords protection against intestinal colo-
nization in mice. The data above suggest that collectively these antigens might significantly ex-
tend coverage presently offered by classical approaches to ETEC vaccine development. We
therefore questioned whether these two antigens could be successfully combined in a subunit
approach. Because we have previously demonstrated that the native secreted EatA passenger
domain will degrade intestinal mucin[29] as well as the EtpA adhesin molecule[22], we elected
Table 3. EtpA sequence conservation in geographically, temporally, and phylogenically disparate isolates.
strain accession origin isolation reported phenotype identity1 (%) Similarity (%) ref.
H10407 AAX13509.2 Bangladesh 1973 cholera-like - - [52]
Throop D 2EMW91721.1 Dallas, TX 1976 cholera-like 97 97 [36]
Juruá 18/11 2EMX66921.1 Amazon, Brazil 1998 cholera-like 94 95 [35]
2720900 2EMX81000.1 Bangladesh 2007 cholera-like 100 100 5
2850750 2EMW11804.1 Bangladesh 2008 cholera-like 94 95 5
2871950 2EMV50451.1 Bangladesh 2011 cholera-like 95 95 5
p0302308.1 2EMX03881.1 Bangladesh 2011 cholera-like 98 98 5
p0304777.1 2EMX02126.1 Bangladesh 2011 cholera-like 99 98 5
p0299438.4 2ENB94816.1 Bangladesh 2011 cholera-like 99 99 5
178900 2ENA69446.1 Bangladesh 2010 cholera-like 97 97 5
180200 2ENA71844.1 Bangladesh 2010 cholera-like 94 95 5
1392/75 YP_003717617.1 Hong Kong - diarrhea4 95 96 [61]
tw11681 3AELD00000000.1 Guinea-Bissau 1996 diarrhea4 96 97 [49]
tw14425 3AELE00000000.1 Guinea-Bissau 1996 diarrhea4 99 100 [49]
tw10828 3AELC00000000.1 Guinea-Bissau 1996 diarrhea4 94 96 [49]
tw10598 3AELA00000000.1 Guinea-Bissau 1996 diarrhea4 95 96 [49]
E24377A 3NC_009786.1 Egypt 1980s diarrhea4 95 96 [63]
1identity and similarity percentages reﬂect BLASTP comparisons of the ﬁrst 600 residues of the EtpA sequence.
2sequenced at GSCID (http://gscid.igs.umaryland.edu/wp.php?wp = comparative_genome_analysis_of_enterotoxigenic_e._coli_isolates_from_infections_
of_different_clinical_severity)
3open reading frames corresponding to the etpA gene were ﬁrst assembled from whole genome shotgun sequence contigs for these draft genomes;
BLASTP for these homologues was conducted using CLC Main Workbench v6.9.1 and local database of predicted protein sequences derived from
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to vaccinate animals with a modified recombinant version of the EatA passenger that lacks pro-
tease activity (rEatApH134R).
Co-vaccination with rEtpA and the mutant rEatApH134R molecule elicited robust serologic
responses to both molecules that were comparable to vaccination with either antigen alone. As
anticipated, each of the groups mounted strong serologic responses to the LT adjuvant
(Fig. 4A), and both antigens retained their immunogenicity following co-immunization of
EtpA with the rEatAH134R passenger domain (Fig. 4B,C) with responses that were at least
comparable to those obtained following immunization with either antigen alone (Fig. 4C).
Likewise, mice immunized with both antigens were significantly protected against colonization
by ETEC (Fig. 4D), although co-vaccination with both antigens did not appear to be more
effective than vaccination with either antigen alone. Collectively, however, these data suggest
that co-immunization with these two antigens is feasible, and could be employed to expand
present approaches to ETEC vaccine antigen selection.
Figure 3. Recognition of novel antigens during naturally occurring ETEC infections in Bangladesh.
Shown are kinetic ELISA data for four different recombinant antigens (a, rEtpA; b, the rEatA passenger
domain; c, rYghJ; and d, rEaeH) obtained with 1:4096 dilutions of convalescent plasma from ETEC-infected
patients hospitalized at ICDDR,B in Dhaka, Bangladesh (closed circles), or control patients not infected with
enterotoxigenic E. coli (open circles). Horizontal bars represent geometric mean Vmax kinetic ELISA values
for each group. P values obtained by two-tailed MannWhitney testing of groups are summarized (*<0.05;
**<0.01; ***<0.001;****<0.0001). x-axis of each graph depicts the specificity of the secondary antibody
used in the ELISA (IgG, IgA, IgM, and total IgG, IgA, and IgM).
doi:10.1371/journal.pntd.0003446.g003
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Discussion
Enterotoxigenic Escherichia coli remain one of the most common causes of infectious diarrhea
worldwide, and severe disease caused by these pathogens persists as leading cause of death
among young children in developing countries[1]. Despite recognition of these toxin produc-
ing E. coli as a cause of severe cholera-like diarrheal illness more than forty years ago[57], there
remains no effective broadly protective vaccine for ETEC.
Figure 4. Mice immunized with rEtpA and rEatApH134R are protected against ETEC infection. Serologic
responses to a heat-labile toxin (LT), b the passenger domain of EatA (Eatp), c EtpA. Shown are serum IgG
responses following intranasal vaccination of mice with the LT adjuvant alone, or LT with 15 μg of either the
proteolytically inactive passenger domain (EatApH134R), EtpA, or both antigens on days 0, 14, 28.
Colonization of mice following immunization with the adjuvant alone compared with single and dual antigen
vaccination. Comparisons between groups were by MannWhitney two tailed nonparametric testing. (One
mouse died during the vaccination period in the LT/EtpA group and was therefore excluded from the
analysis). For mice with no detectable colonies following challenge, the number of cfu is arbitrarily reported as
1 (10°) cfu, the theoretical limit of detection.
doi:10.1371/journal.pntd.0003446.g004
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Most vaccinology efforts to date have focused almost exclusively on a subset of plasmid-en-
coded antigens, namely the colonization factors (CFs) and heat-labile toxin[9]. Vaccines based
on this strategy have faced several impediments. First, the CFs are quite diverse with more than
26 distinct antigens described to date. In addition, a number of recent vaccine studies have sug-
gested that simply engendering immune responses to CFs and/or heat-labile toxin may not be
sufficient to provide sustained broad-based protection[14–16].
Recent studies of ETEC pathogenesis suggest that a number of virulence factors in addition
to the CFs are involved in efficient delivery of toxins to their cognate receptors on the epithelial
surface[2,22,29,30,48,58]. Similarly, the immune response to ETEC infection appears to involve
many proteins[25,47] in addition to the classical antigens that are the present focus of most
vaccines. Collectively, these findings suggest that there may be additional molecules that could
be targeted to interdict toxin delivery by these pathogens, expand the list of potential protective
antigens, and complement existing approaches to vaccine development for ETEC[59,60].
A major challenge to ETEC vaccine development in general is that the most highly con-
served antigens of ETEC, typically encoded on core regions of the chromosome, are also shared
with commensal E. coli[60]. Included among these chromosomally encoded conserved proteins
are two antigens studied here, YghJ[27] and EaeH[28] that were recently shown to be impor-
tant for ETEC virulence. While the present studies also demonstrate that these proteins are rec-
ognized during the course of ETEC infection, the degree to which these antigens can be safely
targeted in vaccines without inadvertent disruption of the intestinal microflora remains to
be studied.
The inherent plasticity of E. coli genomes contributes substantially to the difficulty in defin-
ing antigens unique to the ETEC pathovar that are widely conserved. No single antigen exclu-
sive to these pathogens, but universally conserved in this pathovar, has been described to date.
Some have suggested that this might be predicted based on the fact that the plasmid-encoded
heat-labile and/or heat-stable toxins, which define the ETEC pathovar, could form a minimal
complement of virulence genes in wide variety of E. coli host strains[61]. Nevertheless, earlier
studies conducted on phlyogenicaly disparate strains from Guinea Bissau[49] and Chile[37]
suggested that genes encoding two pathogen-specific antigens EatA and EtpA were present in a
majority of strains.
In this context, we examined the gene conservation and the actual production of these pro-
teins in a large collection of well-characterized strains from Bangladesh, complemented by
strains from other locations that were associated with severe disease and for which there were
available clinical metadata. Notably, two plasmid-encoded ETEC pathotype-specific antigens,
the EatA serine protease and the secreted EtpA adhesin molecule were shared broadly among
strains belonging to different CF groups with the exception of strains that produced CFA/IV
antigens CS4, CS5, CS6 which only infrequently produced EtpA.
The studies reported here represent the largest screen for EtpA and EatA secretion in ETEC
performed to date. Earlier studies reporting that genes encoding both proteins were highly con-
served relied on either PCR[37] or screening of draft genomes[49] for the presence of the corre-
sponding loci. In general, we found high degrees of concordance between the presence of these
genes by PCR and production of the corresponding protein. We should point out however that
draft genome assemblies typically fail to encompass the entire etpA gene as automated assem-
bly algorithms cannot faithfully incorporate the multiple repeat regions comprising two thirds
of etpA. This could impact interpretation of gene prevalence in ongoing large-scale ETEC ge-
nome sequencing projects. The prevalence of EtpA and EatA (56 and 59%, respectively) as de-
termined by examination of protein expression in our study was slightly lower than previously
reported in earlier studies that analyzed strains from Guinea Bissau, where both genes were
present in 75% of strains [49]; or Chile, where etpA and eatA, were present in 71 and 75% of
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strains, respectively[37]. Nevertheless similar to these earlier studies, the strains that produced
these antigens belonged to many different phylogenies suggesting that genes encoding these
antigens have been widely dispersed.
The analyses of strains in these studies largely focused on isolates from Bangladesh. Howev-
er, these data are potentially relevant for vaccine development for a number of reasons. First,
Bangladesh is highly endemic for enterotoxigenic E. coli infections, and consequently remains
an important site for vaccine field trials. In addition, ETEC has been under study in this region
since the discovery of this pathotype, permitting us to compare sequence variation in candidate
antigens over four decades. Understanding both current prevalence and sequence conservation
of potential novel vaccine antigens in this population over time will be particularly important
for making rational decisions about their inclusion in future iterations of ETEC vaccines. Final-
ly, the geographic and temporal dispersal of genes encoding EtpA and EatA in multiple phylo-
genic backgrounds, further attests to importance of studying these molecules as potential
vaccine targets as previously suggested by others[37,49].
The optimal formulation of an ETEC vaccine has yet to be defined, and many questions per-
taining to the nature of protective immunity that develops following infections with these path-
ogens remain. Nevertheless, the data presented here do suggest that the novel pathovar-specific
antigens could complement existing strategies for ETEC vaccine development by broadening
the antigenic valency. Whether the expanded coverage afforded by inclusion of additional
pathotype specific antigens would enhance vaccine efficacy beyond that presently achieved by
targeting CFs and LT will need to be determined empirically.
Supporting Information
S1 Fig. EatA passenger domain alignments of predicted EatA sequences corresponding to
multiple phylogenies from strains belonging to disparate geographic origins. The conserved
catalytic triad at amino acids H78, D106, and S211 is highlighted by gray background shading.
Geographic origin of strains is depicted in the color key at left of the alignment. Alignments
were performed using CLUSTAL Omega (release 1.2.0 AndreaGiacomo) [40] algorithm plugin
for CLCMain Workbench.
(PDF)
S2 Fig. EtpA alignments of predicted sequences corresponding to multiple phylogenies
from strains belonging to disparate geographic origins. Geographic origin of strains is de-
picted in the color key at left of the alignment. Alignments were performed using sequence
alignment algorithm of CLC Main Workbench v6.9.1 with the following parameters: gap open
cost = 10.0; gap extension cost = 1.0; end gap cost = as any other; alignment mode = very accu-
rate (slow); redo alignments = no; use fixpoints = no.
(PDF)
S3 Fig. Immune response to selected ETEC proteins in infected patients and Bangledeshi
and US controls. Shown are (IgG) kinetic ELISA responses (in Vmax, milli-units/min) to re-
combinant proteins comparing convalescent plasma from patients hospitalized with acute
ETEC infections at the International Centre for Diarrhoeal Disease Research in Dhaka, Bangla-
desh with controls (c) from Bangledeshi adults, and children, as well as plasma from age-
matched children from Saint Louis Children’s Hospital (slch). Antigens included two plasmid-
encoded ETEC specific antigens (a) EtpA, and (b) the EatA passenger domain; and two chro-
mosomally-encoded conserved antigens (c) YghJ, and (d) EaeH. All plasma samples were dilut-
ed 1:4096.
(PDF)
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S4 Fig. Immune responses to EtpA following volunteer challenge with ETEC H10407. All
sera were diluted 1:4096 prior to testing against rEtpA-myc-6His followed by detection of total
antibody (IgM,IgG,IgA) in kinetic ELISA. Pre and post values (open and closed circles, respec-
tively) represent collective data from 2 independent ETEC H10407 challenge studies CIR218
and CIR193a. Data from CIR218 are shown as pre-challenge (d-2, open blue circles) and (d28,
closed blue circles), while data from CIR193a appear as open grey circles (pre-challenge, d0)
and closed grey circles (post challenge, d9). Dashed horizontal lines represent geometric
means. P value represents comparison of pre and post-challenge samples by MannWhitney
2-tailed analysis.
(PDF)
S1 Table. Oligonucleotide primers used in this study. Shown in the table are oligonucleotide
pairs, and predicted product sizes for ETEC pathotype-specific virulence gene amplification in
these studies.
(PDF)
S1 Dataset. S1 Dataset.xlsx contains the complete listing of all 181 strains analyzed for pro-
duction of the secreted EtpA, EatA antigens (tab 1), and YghJ (tab 2). Tab 3 shows 91
unique isolates sequenced by the Genome Sequencing Center for Infectious Diseases (GSCID)
which were screened for the presence of the eaeH gene by BLASTP homology searches. Note
that in the dataset, disease severity is classified numerically (0 = isolate from asymptomatic
colonization, 1 = mild disease, 2 = severe cholera-like illness). The presence or absence of a
given protein or gene in each strain is defined in a binary fashion where 1 = yes; 0 = no.
(XLSX)
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